Pierre Carlotti has been appointed as the new marketing director of Valois Pharmaceuticals, Paris.
He had previously worked for Synthelabo.
Paul Fry has joined RSSL-Pharma to head up its product formulation service. Most recently, he has developed a wide range of own label products in the contract manufacturing sector.
KPMG corporate finance has appointed Gerard Gregg-Smith to lead its healthcare and sciences team. He will work in the European consumer and other global markets.
George Blitz has been named global business leader for Dow CMS, replacing Margaret Walker, who has accepted a position in Dow Operations.
Cubist Pharmaceuticals, Cambridge, MA, US has appointed Dinendra Sen to the position of president and chief operating officer. Sen was recently vp at Pathogensis, with responsibilities for sales and marketing.
MAT has appointed Peter Bradley to the role of export manager for the company's range of healthcare equipment. He has responsibility for all overseas activities.
Paul Reeve has been appointed by the Chemical Industries Association to the position of executive director. Reeve replaces Dr Stuart Aaron, who retired at the end of March after seven years.
Coventry based, UK process engineering services provider, CEL International has opened a Scottich office, which will be run by Euan McKenzie.
Rhodia Pharmaceutical has appointed Antoine Baule as president, replacing Marc-Antione Mallet, who has been appointed president of Rhodia ChiRex.